论文部分内容阅读
目的:主要研究缬沙坦联合氨氯地平治疗社区老年原发高血压合并糖尿病的临床疗效。方法:选取我院于2015年3月-2016年8月间收治的56例老年原发高血压合并糖尿病患者,随机将其分为观察组、对照组,其中观察组患者28例,接受缬沙坦联合氨氯地平治疗;对照组患者28例,接受氨氯地平治疗,比较两组治疗效果。结果:比较两组患者治疗前后的血压变化及空腹血糖变化情况,观察组明显优于对照组(P<0.05)。结论:缬沙坦联合氨氯地平在治疗社区老年原发高血压合并糖尿病中发挥重要作用,有助于快速改善患者血压及血糖水平,应该成为临床治疗的首选方法。
Objective: To study the clinical efficacy of valsartan combined with amlodipine in the treatment of elderly patients with essential hypertension complicated with diabetes mellitus. Methods: A total of 56 elderly patients with primary hypertension and diabetes mellitus admitted to our hospital from March 2015 to August 2016 were randomly divided into observation group, control group, 28 patients in observation group, Tan combined with amlodipine treatment; control group of 28 patients, received amlodipine treatment, the two groups were compared. Results: The changes of blood pressure and fasting blood glucose before and after treatment in both groups were significantly better than those in the control group (P <0.05). Conclusion: Valsartan combined with amlodipine play an important role in the treatment of community-aged elderly patients with primary hypertension and diabetes mellitus. It is helpful to rapidly improve the blood pressure and blood glucose level of the patients and should be the first choice of clinical treatment.